Advanced search
Publication Cover
International Journal of General Medicine Volume 13, 2020 - Issue
Submit an article Journal homepage
539
Views
17
CrossRef citations to date
0
Altmetric
Review

Safety Considerations in Cannabinoid-Based Medicine

Sven Gottschling1 Universitätsklinikum des Saarlandes, Homburg (Saar), GermanyView further author information
,
Oyedeji Ayonrinde2 Queen’s University, Kingston, Ontario, CanadaView further author information
,
Arun Bhaskar3 Imperial College Healthcare NHS Trust, London, UKView further author information
,
Marc Blockman4 University of Cape Town and Groot Schuur Hospital, Cape Town, South AfricaORCID Iconhttps://orcid.org/0000-0001-7240-8812View further author information
ORCID Icon,
Oscar D’Agnone5 The OAD Clinic, London, UKView further author information
,
Danial Schecter6 Spectrum Therapeutics, Smiths Falls, Ontario, CanadaView further author information
,
Luis David Suárez Rodríguez7 Centro de Medicina Integrativa Sanar, Playa del Carmen, MexicoView further author information
,
Sherry Yafai8 The Releaf Institute, Santa Monica, CA, USAView further author information
&
Claude Cyr9 McGill University, Montreal, Quebec, CanadaCorrespondence[email protected]
View further author information
 show all
Pages 1317-1333 | Published online: 01 Dec 2020

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Luke J Ney, Wole Akosile, Chris Davey, Louise Pitcher, Kim L Felmingham, Leah M Mayo, Matthew N Hill & Esben Strodl. (2023) Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician’s perspective. Expert Review of Clinical Pharmacology 16:11, pages 1093-1108.
Read now
Ryan S. D’Souza, Brendan Langford, Rachel E. Wilson, Yeng F. Her, Justin Schappell, Jennifer S. Eller, Timothy C. Evans & Jonathan M. Hagedorn. (2022) The state-of-the-art pharmacotherapeutic options for the treatment of chronic non-cancer pain. Expert Opinion on Pharmacotherapy 23:7, pages 775-789.
Read now

Articles from other publishers (15)

Varinder Kaur, Simon Erridge, Mikael H Sodergren & James J Rucker. (2023) Medical cannabis and attention-deficit hyperactivity disorder. British Journal of Neuroscience Nursing 19:2, pages 65-70.
Crossref
Anjalika Eeswara, Amanda Pacheco-Spiewak, Stanislava Jergova & Jacqueline Sagen. (2023) Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model. PLOS ONE 18:3, pages e0282920.
Crossref
Trang Nguyen, Yunshu Li, Danielle Greene, Sharon Stancliff & Nicole Quackenbush. (2023) Changes in Prescribed Opioid Dosages Among Patients Receiving Medical Cannabis for Chronic Pain, New York State, 2017-2019. JAMA Network Open 6:1, pages e2254573.
Crossref
Arthur Cassa Macedo, André Oliveira Vilela de Faria, Isabella Bizzi, Fabrício A. Moreira, Alessandro Colasanti & Pietro Ghezzi. (2022) Online information on medical cannabis is not always aligned with scientific evidence and may raise unrealistic expectations. Journal of Cannabis Research 4:1.
Crossref
Stephan Ott, Anne Herrmann-Werner, Stephan Zipfel & Barbara Schlisio. (2022) SOP Dronabinol und andere Cannabinoide in der Schmerztherapie. PSYCH up2date 16:05, pages 371-377.
Crossref
Caroline A. MacCallum, Lindsay A. Lo, Carly A. Pistawka, April Christiansen, Michael Boivin & Melissa Snider-Adler. (2022) A Clinical Framework for Assessing Cannabis-Related Impairment Risk. Frontiers in Psychiatry 13.
Crossref
Caroline Vuilleumier, Norbert Scherbaum, Udo Bonnet & Patrik Roser. (2022) Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials. Frontiers in Psychiatry 13.
Crossref
David LazrisDhruv GaurKimberly CurseenDio Kavalieratos, Meredith MaxwellTammie QuestAli John Zarrabi. (2022) Integrated Medical Cannabis Consultations in a Palliative Care Program: Policies, Procedures, and Progress after Six Years of Practice. Journal of Palliative Medicine 25:5, pages 802-806.
Crossref
Susan Mohamed, Giovanna Lopane, Loredana Sabattini, Cinzia Scandellari, Diletta Zardi, Vincenzo Donadio, Giovanni Rizzo, Alessandro Perrone, Alessandra Lugaresi & Manuela Contin. (2022) Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey. Frontiers in Neurology 13.
Crossref
M. M. Dziwenka & R. W. Coppock. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 1353 1368 .
M. M. Dziwenka & R. W. Coppock. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 1 17 .
Babak Baban, Hesam Khodadadi, Évila Lopes Salles, Vincenzo Costigliola, John C. Morgan, David C. Hess, Kumar Vaibhav, Krishnan M. Dhandapani & Jack C. Yu. (2021) Inflammaging and Cannabinoids. Ageing Research Reviews 72, pages 101487.
Crossref
Barbara Stella, Francesca Baratta, Carlo Della Pepa, Silvia Arpicco, Daniela Gastaldi & Franco Dosio. (2021) Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain. Drugs 81:13, pages 1513-1557.
Crossref
Caroline A. MacCallum, Lindsay A. Lo & Michael Boivin. (2021) “Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations. European Journal of Internal Medicine 89, pages 10-18.
Crossref
Caroline A. MacCallum, Lauren Eadie, Alasdair M. Barr, Michael Boivin & Shaohua Lu. (2021) Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain. Frontiers in Pharmacology 12.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.